Morgan Stanley cuts Lemonade stock rating, slashes target to $24

Published 08/04/2025, 09:28
© Ben Kelmer, Lemonade PR

On Tuesday, Lemonade Inc . (NYSE:LMND) shares faced a downgrade from Morgan Stanley (NYSE:MS), moving from an Equalweight to an Underweight rating. Accompanying this adjustment, the firm significantly reduced the price target for Lemonade stock to $24.00 from the previous $35.00. The stock, currently trading at $28.11, has shown significant volatility with a beta of 2.13, according to InvestingPro data. This comes after a challenging period where the stock has declined 11% in the past week, despite being up 65% over the last year.

Morgan Stanley analysts cited several reasons for the downgrade. They pointed out that Lemonade's decision to enter the highly competitive auto insurance market comes with increased risks due to current market conditions. The analysts expressed concerns over the impact of tariffs, heightened competition from established companies, and broader macroeconomic uncertainties, which could pose challenges to Lemonade's goal of significantly growing its business. While the company has demonstrated strong revenue growth of 22.5% in the last twelve months, reaching $526.5 million, its path to profitability remains uncertain.

The analysts also noted that while Lemonade has been progressing toward profitability, it remains several years away from achieving a GAAP net income profit. The firm's analysts believe that given the macroeconomic uncertainties, Lemonade's stock is likely to underperform compared to its property and casualty (P&C) insurance peers.

The downgrade reflects Morgan Stanley's view that Lemonade's strategic moves into new markets may not be as promising as previously anticipated. This sentiment is further reinforced by the lowered price target, suggesting a more cautious outlook on the company's financial performance in the near term.

Lemonade's initiative to "10x the business," as mentioned by the analysts, refers to the company's ambitious growth plans. However, Morgan Stanley's analysis suggests that the path to achieving such growth is fraught with more obstacles than initially expected.

Investors and market watchers will likely monitor Lemonade's performance closely as it navigates the challenges outlined by Morgan Stanley. The company's efforts to achieve profitability and expand its market share in the competitive auto insurance industry will be critical factors in determining its future success and stock performance. InvestingPro analysis indicates the stock is currently undervalued, with a "Fair" overall financial health score. For deeper insights into Lemonade's valuation and growth prospects, investors can access the comprehensive Pro Research Report, which provides detailed analysis of key metrics and growth drivers.

In other recent news, Lemonade Inc. reported its fourth-quarter 2024 earnings, showcasing a notable revenue increase and a reduced net loss compared to the previous year. The company achieved a revenue of $149 million, surpassing the forecast of $145.02 million, and reported an earnings per share (EPS) of -$0.42, better than the anticipated -$0.61. Despite these positive results, Lemonade's stock experienced a decline, reflecting investor concerns about future profitability. The company has set ambitious targets, aiming to become EBITDA positive by 2026 and achieve GAAP net income positive by 2027.

Lemonade's strategic expansion efforts are evident as the company continues to grow its car insurance product, now available in eight states. The firm also reported its first cash flow positive year, with $48 million in positive cash flow. Analyst discussions during the earnings call highlighted the impact of California wildfires, which resulted in a $45 million gross loss, and the company's response using AI technology to handle claims efficiently. Lemonade's management remains optimistic about the company's growth trajectory, with plans to increase growth spending by approximately 40% year-over-year. Additionally, analysts from Morgan Stanley and Oppenheimer have shown interest in Lemonade's strategy and financial outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.